Your Location：
Home >
Browse articles >
Lentiviral-mediated siRNA against osteopotin in U251 glioma cell line
Updated：2026-03-12
Previous|Next

    • Lentiviral-mediated siRNA against osteopotin in U251 glioma cell line

    • Xu Tao1 , Chen Juxiang1 , Lu Yicheng1 , Zhou Jinxu1 , Yan Yong1 , Hu Guohan1 , Luo Chun1 , Huang Yan2 1Department of Neurosurgery , Changzheng Hospital , Second Military Medical University , Shanghai Neurosurgical Institute , Shanghai 200003 , China 2 State Key Laboratory of Genetic Engineering , Institute of Genetics , School of Life Science , Fudan University , Shanghai 200433 , China
    • Military Medical Research Vol. 25, Issue 1, Pages: 1-10(2010)

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

3

Views

33

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Frostbite: diagnosis, treatment, prognosis, and future directions
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

Related Author

No data

Related Institution

No data